News item
Former company and directors behind BioV8 to face court for alleged unlawful advertising of peptides
We have started Federal Court proceedings against BioV8 (now in liquidation) and its former directors, alleging they breached the Therapeutic Goods Act 1989 by unlawfully advertising prescription-only therapeutic products, including peptides.
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.